We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The first fenestrated endograft for the treatment of abdominal aortic aneurysm
(AAA) in Cook's pilot study of advanced endovascular treatments for this life-threatening
condition has been implanted.
Wright Medical announced a reimbursement "J" code has been assigned
for the company's GRAFTJACKET Ulcer Repair Matrix, a treatment for chronic wounds
often associated with diabetes.
Recom Managed Systems, in conjunction with the Duke Clinical Research Institute,
of Durham, N.C., has announced its Sponsored Research trial is underway.
Nanogen, developer of advanced diagnostic products, has announced the appointment
of Robert Saltmarsh as CFO. Saltmarsh joined Nanogen as vice president of corporate
development last September.
AMDL, developer and marketer of tests for the early detection of cancer and
other serious diseases, has announced its consultant, Diagnostic Oncology Clinical
Research Organization, submitted to the FDA, on behalf of AMDL, additional data
and a new application for 510(k) clearance to market AMDL's DR-70 test as an
aid in monitoring patients previously diagnosed with progressing colorectal
cancer.
RITA Medical Systems has announced its wholly owned subsidiary Horizon Medical
Products entered into an agreement allowing it to repay $6.5 million in debt
held by creditors of Horizon.
CryoFluor Therapeutics, a medical device company developing a novel cryosurgical
technology platform, has received a second investment that will allow the company
to complete a feasibility clinical trial of its device to treat abnormal uterine
bleeding.
Medical device company American Bio Medica has said that the FDA cleared its
Rapid TEC4 drugs of abuse test and also received a Canadian patent related to
its rapid drug screen product.
I-Flow announced that Volker Jacobs and John Morrison of the Fayette Medical
Center (FMC) presented data highlighting benefits of ON-Q PainBuster to reduce
pain after mastectomy while reducing or eliminating the use of narcotics at
the San Antonio Breast Cancer Symposium in December.